CD274 and cancer: The PD-1 and its ligand, programmed death-ligand 1 (PD-L1), can effectively inhibit the cytotoxic effect of CD8+ T cells, which is one of the most important pathways for enhancing anti-cancer effects [17] or immunotherapy effect on autoimmune diseases [18, 19].